2019
DOI: 10.3389/fchem.2019.00634
|View full text |Cite
|
Sign up to set email alerts
|

Biological Activity Evaluation of Some New Benzenesulphonamide Derivatives

Abstract: Bacterial resistance to antibiotics has become one of the most challenging problems of infectious disease treatment. Ten new derivatives of benzenesulphonamide bearing carboxamide functionality were synthesized and investigated for their in vivo anti-inflammatory, in vitro anti-microbial and anti-oxidant activities. The base promoted reactions of the appropriate amino acids with substituted benzenesulphonyl chlorides gave the benzene sulphonamides (3a-j) in excellent yields. Palladium mediated amidation of the… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
16
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 30 publications
(18 citation statements)
references
References 32 publications
2
16
0
Order By: Relevance
“…As shown, numerous interactions between human peroxiredoxin 5-selected phytocompounds are close to the active site of the enzyme. Our finding also corroborates perfectly those of Eze et al [ 54 ], demonstrating that the docked 1-(Phenylsulphonyl)-N-propylpyrrolidine-2-carboxamide with human peroxiredoxin 5 exhibited higher binding energy (−13.86 kcal mol −1 ), creating interactions with Thr44, Pro40, Pro 45, Gly46, Arg127, Thr147, and Cys47 residues. Additionally, with the same therapeutic target, caryophyllene oxide (−7.2 kcal/mol) from Cymbopogon citratus essential oil established non-covalent interactions with Pro 40, Thr 147, Thr 44, Phe 120, Pro 45, Leu 116, and Ile 119, sharing a large number of common residues with the active site of the investigated enzyme.…”
Section: Discussionsupporting
confidence: 92%
“…As shown, numerous interactions between human peroxiredoxin 5-selected phytocompounds are close to the active site of the enzyme. Our finding also corroborates perfectly those of Eze et al [ 54 ], demonstrating that the docked 1-(Phenylsulphonyl)-N-propylpyrrolidine-2-carboxamide with human peroxiredoxin 5 exhibited higher binding energy (−13.86 kcal mol −1 ), creating interactions with Thr44, Pro40, Pro 45, Gly46, Arg127, Thr147, and Cys47 residues. Additionally, with the same therapeutic target, caryophyllene oxide (−7.2 kcal/mol) from Cymbopogon citratus essential oil established non-covalent interactions with Pro 40, Thr 147, Thr 44, Phe 120, Pro 45, Leu 116, and Ile 119, sharing a large number of common residues with the active site of the investigated enzyme.…”
Section: Discussionsupporting
confidence: 92%
“…Our molecular docking results with antioxidant human peroxiredoxin 5 were perfectly correlated with those of Eze et al [105], confirming the same and highest binding pose of 1-(phenylsulphonyl)-N-propylpyrrolidine-2-carboxamide in the binding cavity of human peroxiredoxin 5 with a binding energy of (−13.86 kcal mol −1 ) and interactions with THR44, PRO40, PRO 45, GLY46, ARG127, THR147, and CYS A47 residues. Similarly, α-tocopherol (−7.2 kcal mol −1 ) Cymbopogon citratus essential oil was perfectly fitted into the cavity of peroxiredoxin 5 establishing H-bonding with Arg 127(A) and non-covalent interactions with ASP A113, THR A147, LEU A116, SER A115, LEU A112, PRO A40, THR A44, GLY A46, CYS A47, PHE A120, and ASP A145.…”
Section: In Silico Studysupporting
confidence: 87%
“…The mechanism of resistance is usually encoded genetically and as such can be transferable 1 . This wide increase in resistance mechanism negatively affects the therapeutic efficacy of a whole class of drugs 2 .…”
Section: Introductionmentioning
confidence: 99%